BioLizard, a leading bioinformatics, data analytics and data engineering consulting company driving digital transformation in the life sciences industry, has been awarded a grant from Flanders Innovation & Entrepreneurship (VLAIO) to develop an AI-powered biomedical knowledge discovery software solution that is part of BioLizard’s Bio|Verse. This innovative application is designed to automate and streamline literature analysis, enabling biotech and pharmaceutical companies to extract critical insights from vast amounts of (un)structured data with unprecedented speed and accuracy.

With over one million biomedical research articles published annually on PubMed alone, reviewing literature is an overwhelming but imperative part of drug development and scientific advancements. It is estimated that research scientists spend about 60% of their time selecting, organizing and cleaning data. Thus, there is a critical need for a solution that can automate and streamline this process, ensuring faster, more reliable and more comprehensive biomedical information extraction. The novel solution developed in the Bio|Verse framework will leverage LLMs to automatically search, extract, and structure information, transforming unstructured text into actionable insights for target identification, drug discovery, and other life sciences applications. The knowledge output gained from structured and unstructured data searches is presented in a visual and interactive dashboards allowing visual analytics and biological interpretation.